Results demonstrated that MAPK, NF-κB, and PI3K/Akt signaling pathway were obviously enriched except NAFLD (Non-alcoholic fatty liver disease) and hepatitis-related pathways (Figure 3A). This evidence concerns the gene NFKB1 and metabolic dysfunction-associated steatotic liver disease.